Maximum tolerated dose of a new drug is evaluated in:
Phase 1 clinical trial: Used to evaluate Maximum tolerated dose (MTD) of a new drug. Healthy human volunteers are used. Done for safety and non-toxicity.
Phase 1
Phase 2
Phase 3
Phase 4
RCT, Trials